Vimarsana
Biggest News Aggregation in the World

Page 9 - Data Types News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Data Types. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Data Types Today - Breaking & Trending Today

CSPAN3 Senior Military Leader Misconduct February 7, 2018 - Vimarsana News

CSPAN3 Senior Military Leader Misconduct February 7, 2018

This subCommittee Hearing is called to order. I want to welcome everyone to this mornings military personnel subCommittee Hearing. The purpose of todays hearing is to receive testimony from the department of defense and the services regarding efforts they have taken to investigate and hold Senior Leaders accountable for misconduct and to understand what programs and policies are in place to prevent misconduct. Our military enjoys the highest confidence rating by far of any End Institution in american society. This well deserved reputation has been earned through the service and sacrifice of mi...

CSPAN3 Broadband Infrastructure February 2, 2018 - Vimarsana News

CSPAN3 Broadband Infrastructure February 2, 2018

Proposals and great work from the staff of those of republican and the democrat side and i look forward to seeing progress. The bills to be extended are targeted and promoting innovation, cutting the red tape and advancing Public Safety. To highlight each though i do want to call attention to a couple of resolutions expressing the Guiding Principles on broadband infrastructure that should underpin our efforts first. Any funds for broadband in an infrastructure package should go to underserved areas. Second, as noted, the federal government should not be picking winners and losers in the market...

CSPAN3 Hearing Looks At Changes To Over-the-Counter Drug Regulation September 14, 2017 - Vimarsana News

CSPAN3 Hearing Looks At Changes To Over-the-Counter Drug Regulation September 14, 2017

The Current System at the United States food and Drug Administration to review, approve and update over the counter drugs. This hearing provides us and the American Public with an opportunity to better understand the food and Drug Administration regulatory pram work to regulate over the counter drugs and consider a proposal to reform the monograph system. Today we will convene two panels of witnesses. First i want to welcome dr. Woodcock back to the subcommittee this morning. Later well hear from representatives of other key stake holders. And commend all for their efforts throughout the negot...

CSPAN3 Hearing Looks At Changes To Over-the-Counter Drug Regulation September 14, 2017 - Vimarsana News

CSPAN3 Hearing Looks At Changes To Over-the-Counter Drug Regulation September 14, 2017

Public discussion on modernizing the Current System at the United States food and Drug Administration to review, approve and update over the counter drugs. This hearing provides us and the American Public with an opportunity to better understand the food and Drug Administration regulatory pram work to regulate over the counter drugs and consider a proposal to reform the monograph system. Today we will convene two panels of witnesses. First i want to welcome dr. Woodcock back to the subcommittee this morning. Later well hear from representatives of other key stake holders. And commend all for t...

CSPAN2 Hearing Looks At Changes To Over-the-Counter Drug Regulation September 15, 2017 - Vimarsana News

CSPAN2 Hearing Looks At Changes To Over-the-Counter Drug Regulation September 15, 2017

A group of industry stakeholders spoke and outlined recommendations for lawmakers. This is about two hours, 40 minutes. We will come to order. I recognize myself for five minutes. Opening statement. Todays hearing marks the health of subsidy public discussion on modernizing the Current System of the United States fda to review, approve and update. This hearing provides us in the American Public with the opportunity to better understand the fda regulatory frame work for overthecounter drugs and consider a proposal to reform the monograph system. I would like to commend all for their efforts in ...